Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Wilburn E. Reddick

ALL therapy and developing brains: MRI measures, genetic factors and cognition

Brain, nervous system Leukaemia

Pediatric oncology or childhood cancer

Timothy Jensen Henrich

Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics

Leukaemia

Hematology and hematologic malignancies

Ellen P Mccarthy

Integrating Competing Risks into the CISNET DFCI Breast Cancer Model

Breast

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Hodgkin lymphoma Non-Hodgkin lymphoma

Kornelia Polyak

Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors

Breast

Xiaofeng Steven Zheng

Role of Rab1 in Cell Growth and Cancer

Breast

Pathology

A. Thomas Look

Discovery of New Targets and Pathways for T-ALL Therapy

Leukaemia

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Hodgkin lymphoma Non-Hodgkin lymphoma